Primary pulmonary hypertension treated with short-term epoprostenol infusion

Intern Med. 2003 Sep;42(9):824-6. doi: 10.2169/internalmedicine.42.824.

Abstract

We describe the use of short-term epoprostenol in a 61-year-old man with primary pulmonary hypertension. The patient was on a ventilator because of respiratory distress. Continuous infusion of epoprostenol was started and it initially reduced the pulmonary artery pressure by 32%. Epoprostenol was tapered, and even after discontinuation, the pulmonary artery pressure was controlled. The ventilator was removed, and the patient remained well on home oxygen therapy 3 months after discharge.

Publication types

  • Case Reports

MeSH terms

  • Antihypertensive Agents / administration & dosage*
  • Epoprostenol / administration & dosage*
  • Humans
  • Hypertension, Pulmonary / complications
  • Hypertension, Pulmonary / drug therapy*
  • Infusions, Parenteral
  • Male
  • Middle Aged
  • Respiration, Artificial / methods
  • Respiratory Insufficiency / etiology
  • Respiratory Insufficiency / therapy*
  • Treatment Outcome
  • Ventilator Weaning

Substances

  • Antihypertensive Agents
  • Epoprostenol